ОбзорГрафикНовостиTraderScreen

UC DIS.CERT. 06/25 22UA/  DE000HD30Y12  /

gettex Zertifikate
15.11.2024  21:46:38 Изменение-0.210 Бид21:56:10 Предложение21:56:10 Базовый актив Цена исполнения Дата истечения Тип опциона
63.400EUR -0.33% 63.350
Величина цены спроса: 4,000		 63.430
Величина цены предложения: 4,000		 BIONTECH SE SPON. AD... - - 27.06.2025 Call
TeleTrader 04.11 BioNTech's revenue at €1.2 billion in Q3
GlobeNewswire 22.08 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 16.08 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
TeleTrader 05.08 BioNTech posts revenue at €128.7 billion in Q2
GlobeNewswire 05.08 BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 30.07 BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...
GlobeNewswire 22.07 BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
GlobeNewswire 27.06 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 24.06 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 01.06 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 29.05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 21.05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 17.05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
TeleTrader 06.05 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 06.05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 22.04 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 07.04 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
TeleTrader 20.03 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 20.03 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20.03 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 11.03 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 07.03 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 06.03 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire 08.02 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 31.01 BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjuga...